Original Literature | Model OverView |
---|---|
Publication
Title
Cytokine signaling modules in inflammatory responses.
Affiliation
Molecular Immunology and Inflammation Branch, National Institute of Arthritis,Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD20852, USA. osheajo@mail.nih.gov
Abstract
Cytokine signaling via a restricted number of Jak-Stat pathways positively andnegatively regulates all cell types involved in the initiation, propagation, andresolution of inflammation. Here, we focus on Jak-Stat signaling in three majorcell types involved in inflammatory responses: T cells, neutrophils, andmacrophages. We summarize how the Jak-Stat pathways in these cells arenegatively regulated by the Suppressor of cytokine signaling (Socs) proteins. Weemphasize that common Jak-Stat-Socs signaling modules can have diversedevelopmental, pro- and anti-inflammatory outcomes depending on the cytokinereceptor activated and which genes are accessible at a given time in a cell'slife. Because multiple components of Jak-Stat-Socs pathways are mutated orclosely associated with human inflammatory diseases, and cytokine-basedtherapies are increasingly deployed to treat inflammation, understandingcytokine signaling will continue to advance our ability to manipulate chronicand acute inflammatory diseases.
PMID
18400190
|
Entity
STAT3
--
MO000013122
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1360
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000013122 |
--
IFN Type I
--
MO000016658
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m1634
10
infinite
0
TRANSPATH | MO000016658 |
--
FAK family
--
MO000016855
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m1787
10
infinite
0
TRANSPATH | MO000016855 |
--
STAT5
--
MO000016876
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1798
10
infinite
0
TRANSPATH | MO000016876 |
--
SOCS-1
--
MO000017004
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1906
10
infinite
0
InterPro | IPR001496 |
TRANSPATH | MO000017004 |
--
SOCS-3
--
MO000017121
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2005
10
infinite
0
InterPro | IPR001496 |
TRANSPATH | MO000017121 |
--
IL-10
--
MO000017247
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2103
10
infinite
0
InterPro | IPR000098 |
TRANSPATH | MO000017247 |
--
CXCL12
--
MO000019001
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3609
10
infinite
0
InterPro | IPR001811 |
TRANSPATH | MO000019001 |
--
protein remnants
--
MO000019479
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m360980
10
infinite
0
TRANSPATH | MO000019479 |
--
IL-22
--
MO000019517
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m4068
10
infinite
0
TRANSPATH | MO000019517 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
cytokine: cytokine receptor: Jak1: Jak2
--
e11
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m11
0
infinite
0
--
cytokine: cytokine receptor {pY}: Jak1: Jak2
--
e12
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m12
0
infinite
0
--
cytokine: cytokine receptor {pY}: Jak1: Jak2: STATs
--
e13
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m13
0
infinite
0
--
STATs {nuclear}: DNA
--
e15
cso30:c:Complex
cso30:i:CC_NuclearChromosome
--
csml-variable:Double
m15
0
infinite
0
--
csml-variable:Double
m16
0
infinite
0
--
IL-7R: gamma-c
--
e17
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m17
0
infinite
0
--
IL-7: IL-7R: gamma-c
--
e18
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m18
0
infinite
0
--
IL-6: IL-6R: gp130
--
e19
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
STAT5{activated}
--
e20
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m20
10
infinite
0
TRANSPATH | MO000016876 |
--
STAT5A {activated}
--
e21
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m21
10
infinite
0
InterPro | IPR000923 |
TRANSPATH | MO000013126 |
--
STAT5B {activated}
--
e22
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m22
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000013133 |
--
STAT4 {activated}
--
e23
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m23
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000017181 |
--
STAT6 {activated}
--
e24
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m24
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000013130 |
--
csml-variable:Double
m26
0
infinite
0
--
STAT5{nuclear}: FOXP3 gene
--
e27
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m27
0
infinite
0
--
STAT3 {activated}
--
e28
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m28
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000013122 |
--
IL23: IL23R: gp130
--
e29
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
IL-21: IL-21R:gamma-c
--
e30
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m30
0
infinite
0
--
STAT3 {nuclear}
--
e31
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m31
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000013122 |
--
csml-variable:Double
m32
0
infinite
0
--
csml-variable:Double
m33
0
infinite
0
--
STAT3 {nuclear}: IL21gene
--
e34
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m34
0
infinite
0
--
STAT3 {nuclear}: IL17gene
--
e35
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m35
0
infinite
0
--
csml-variable:Double
m36
10
infinite
0
Affymetrix | 1425792_a_at |
Ensembl | ENSMUSG00000028150 |
MGD | Rorc |
Proteome | HumanPSD/Rorc |
RefSeq | NM_011281 |
TRANSFAC | G009892 |
Unigene | Mm.4372 |
--
SOCS
--
e37
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m37
0
infinite
0
--
culin
--
e38
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m38
0
infinite
0
--
csml-variable:Double
m39
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
csml-variable:Double
m40
0
infinite
0
--
SOCS
--
e41
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m41
0
infinite
0
--
cytokine: cytokine receptor {pY}: Jak1: Jak2: STATs: E3 ubiquitin ligase
--
e42
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m42
0
infinite
0
--
cytokine: cytokine receptor {pY} {ub}: Jak1: Jak2: STATs: E3 ubiquitin ligase
--
e43
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m43
0
infinite
0
--
G-CSF: GCSFR
--
e44
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m44
0
infinite
0
--
G-CSF: GCSFR: SOCS-3
--
e46
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m46
0
infinite
0
--
AIR
--
e47
cso30:c:mRNA
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m47
0
infinite
0
--
IL-6: IL-6R: gp130: STAT3
--
e48
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m48
0
infinite
0
--
IL-6: IL-6R: gp130: STAT3
--
e49
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m49
0
infinite
0
--
cytokine receptor: Jak1: Jak2
--
e5
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
cytokine: cytokine receptor: Jak1: Jak2
--
e6
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
IL23: IL23R: gp130: STAT3
--
e63
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m63
0
infinite
0
--
IL23: IL23R: gp130: STAT3{activated}
--
e64
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m64
0
infinite
0
--
IL-6: IL-6R: gp130: SOCS3
--
e65
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m65
0
infinite
0
--
IL23: IL23R: gp130: SOCS3
--
e66
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m66
0
infinite
0
--
IL-10: IL-10R
--
e67
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m67
0
infinite
0
--
S1008A
--
e68
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m68
0
infinite
0
--
TLR ligand: TLR
--
e69
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m69
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
MAL {p}
--
e70
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m70
0
infinite
0
--
MAL{p}: SOSC-1
--
e71
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m71
0
infinite
0
--
csml-variable:Double
m73
0
infinite
0
--
zymosan
--
e75
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m77
0
infinite
0
--
STAT1 {activated}
--
e77
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m79
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000013119 |
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
m6*0.1
nodelay
--
0
PMID: 18400190 Upon cytokine binding to their cognate receptor, the receptor-associated Jaks are activated and in turn phosphorylate tyrosine residues in the receptor cytoplasmic domain.
p10
p10
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c24 : 1
stoichiometry:c27 : 1
stoichiometry:c150 : 1
stoichiometry:c25 : 1
m1371*m18*0.1
nodelay
--
0
PMID: 18400190, 16418296 IL-7 activates Stat5a and Stat5b, and deletion of the locus encoding Stat5a and Stat5b also results in a severe SCID phenotype. PMID: 18400190 Socs3 is an important inhibitor of cytokines that use gp130 (IL-23R and IL-6R), whereas Socs1 is anticipated to inhibit any cytokines that use gamma-c (IL-7, IL-21 as shown).
p11
p11
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c49 : 1
stoichiometry:c172 : 1
m20*m131*0.1
nodelay
--
0
PMID: 18400190 Stat5 signaling from cytokines that use ¦Ãc is essential for T cell development. PMID: 18400190, 16455959 Deficiency of gamma-c or Jak3 causes a failure to produce Foxp3-positive regulatory T cells. PMID: 18400190 On one hand, Socs1 regulates T cell development by inhibiting gamma-c signaling.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c30 : 1
m27*0.1
nodelay
--
0
PMID: 18400190 Stat5 signaling controls the development of FoxP3-positive Treg cells in part through the direct activation of Foxp3 gene expression. PMID: 18400190 Stat5 appears to have very direct effects on Treg cells in that these transcription factors bind directly to the Foxp3 gene.
p13
p13
cso30:i:ME_UnknownActivation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c35 : 1
stoichiometry:c32 : 1
m2053*m2121*0.1
nodelay
--
0
PMID: 18400190 IL-12 activates Stat4, whereas IL-4 activates Stat6.
p14
p14
cso30:i:ME_UnknownActivation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c33 : 1
stoichiometry:c36 : 1
stoichiometry:c34 : 1
m1368*m1947*0.1
nodelay
--
0
PMID: 18400190 IL-12 activates Stat4, whereas IL-4 activates Stat6.
PMID: 18400190 These fates are driven by the cytokine milieu with IL-12 driving Th1 cell differentiation and IL-4 promoting Th2 cell differentiation. PMID: 18400190, 11121747 Stat4- and Stat6-deficient mice have impaired Th1 and Th2 cell responses, respectively. PMID: 18400190, 12242445 Depending upon the circumstance, type I IFN signaling may enhance or inhibit Th1 cell responses.
PMID: 18400190 These fates are driven by the cytokine milieu with IL-12 driving Th1 cell differentiation and IL-4 promoting Th2 cell differentiation. PMID: 18400190, 11121747 Stat4- and Stat6-deficient mice have impaired Th1 and Th2 cell responses, respectively.
p17
p17
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c39 : 1
stoichiometry:c41 : 1
stoichiometry:c40 : 1
m2053*m1634*0.1
nodelay
--
0
PMID: 18400190 In this regard, it is important to note that type I IFNs also activate Stat4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c42 : 1
m20*0.1
nodelay
--
0
PMID: 18400190 Stat5 appears to have very direct effects on Treg cells in that these transcription factors bind directly to the Foxp3 gene.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c44 : 1
stoichiometry:c45 : 1
m25*m26*0.1
nodelay
--
0
PMID: 18400190 Stat5 appears to have very direct effects on Treg cells in that these transcription factors bind directly to the Foxp3 gene.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c6 : 1
stoichiometry:c7 : 1
m11*0.1
nodelay
--
0
PMID: 18400190 Upon cytokine binding to their cognate receptor, the receptor-associated Jaks are activated and in turn phosphorylate tyrosine residues in the receptor cytoplasmic domain.
p20
p20
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c47 : 1
stoichiometry:c48 : 1
m21*m22*0.1
nodelay
--
0
PMID: 18400190, 17227828 Accordingly, deficiency of both Stat5a and Stat5b also leads to loss of Treg cells and inability to induce Treg cells in vitro. PMID: 18400190 In both cases, cytokines that use gamma-c are important drivers of Treg cell development.
p21
p21
cso30:i:ME_Translation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c61 : 1
stoichiometry:c152 : 1
stoichiometry:c51 : 1
m94226*m30*0.1
nodelay
--
0
PMID: 18400190, 17581589, 17581537 Th17 cells can be generated from naive CD4+ T cells by IL-6 and TGF-beta but can also produce another cytokine IL-21, which promotes IL-17 production in an autocrine-paracrine manner.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c54 : 1
m48*0.1
nodelay
--
0
PMID: 18400190 IL-6, IL-21, and IL-23 all activate Stat3 via their cognate receptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c132 : 1
stoichiometry:c133 : 1
m63*0.1
nodelay
--
0
PMID: 18400190 IL-6, IL-21, and IL-23 all activate Stat3 via their cognate receptors.
p24
p24
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c59 : 1
stoichiometry:c151 : 1
stoichiometry:c56 : 1
m1360*m30*0.1
nodelay
--
0
PMID: 18400190 IL-6, IL-21, and IL-23 all activate Stat3 via their cognate receptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c68 : 1
stoichiometry:c66 : 1
m31*m32*0.1
nodelay
--
0
PMID: 18400190, 16698929, 17884812 However, Stat3 also directly regulates the expression of Il21 and Il17.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c69 : 1
stoichiometry:c67 : 1
m31*m33*0.1
nodelay
--
0
PMID: 18400190, 16698929, 17884812 However, Stat3 also directly regulates the expression of Il21 and Il17.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c62 : 1
stoichiometry:c63 : 1
m28*0.1
nodelay
--
0
PMID: 18400190, 16698929, 17884812 However, Stat3 also directly regulates the expression of Il21 and Il17.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c71 : 1
m34*0.1
nodelay
--
0
PMID: 18400190, 16698929, 17884812 However, Stat3 also directly regulates the expression of Il21 and Il17.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c73 : 1
stoichiometry:c72 : 1
m35*0.1
nodelay
--
0
PMID: 18400190, 16698929, 17884812 However, Stat3 also directly regulates the expression of Il21 and Il17.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m5*m3957*0.1
nodelay
--
0
PMID: 18400190 Upon cytokine binding to their cognate receptor, the receptor-associated Jaks are activated and in turn phosphorylate tyrosine residues in the receptor cytoplasmic domain.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c76 : 1
m31*0.1
nodelay
--
0
PMID: 18400190, 18164222 Accordingly, selective deletion of Stat3 in T cells abrogates Th17 cell differentiation in part because the expression of RORgammat and RORalpha, two nuclear hormone receptors essential for Th17 cell development, is also abrogated. PMID: 18400190 IL-23 and IL-6 enforce Th17 cell development via the direct or indirect induction of Rorc and Rora expression.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c77 : 1
m31*0.1
nodelay
--
0
PMID: 18400190, 18164222 Accordingly, selective deletion of Stat3 in T cells abrogates Th17 cell differentiation in part because the expression of RORgammat and RORalpha, two nuclear hormone receptors essential for Th17 cell development, is also abrogated. PMID: 18400190 IL-23 and IL-6 enforce Th17 cell development via the direct or indirect induction of Rorc and Rora expression.
p32
p32
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c78 : 1
stoichiometry:c79 : 1
stoichiometry:c83 : 1
m36*m94396*0.1
nodelay
--
0
PMID: 18400190, 18164222 Accordingly, selective deletion of Stat3 in T cells abrogates Th17 cell differentiation in part because the expression of RORgammat and RORalpha, two nuclear hormone receptors essential for Th17 cell development, is also abrogated. PMID: 18400190 IL-23 and IL-6 enforce Th17 cell development via the direct or indirect induction of Rorc and Rora expression. PMID: 18400190, 17363300 Parenthetically, it is interesting to note that IL-2 acting through Stat5 inhibits Th17 cell differentiation.
p33
p33
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c82 : 1
stoichiometry:c81 : 1
m1798*m1954*0.1
nodelay
--
0
PMID: 18400190, 17363300 Parenthetically, it is interesting to note that IL-2 acting through Stat5 inhibits Th17 cell differentiation.
p34
p34
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c85 : 1
m19*m2269*0.1
nodelay
--
0
PMID: 18400190 whereas IL-6 and TGF-beta-1 are important for the differentiation of Th17 cells, IL-6 alone so far appears to be capable of inducing IL-22.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c87 : 1
m19*0.1
nodelay
--
0
PMID: 18400190 whereas IL-6 and TGF-beta-1 are important for the differentiation of Th17 cells, IL-6 alone so far appears to be capable of inducing IL-22.
p36
p36
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c88 : 1
stoichiometry:c90 : 1
stoichiometry:c89 : 1
m1360*m4068*0.1
nodelay
--
0
PMID: 18400190 An additional complexity of Th17 T cells in inflammation concerns the Stat3-activating cytokine IL-22.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c92 : 1
stoichiometry:c91 : 1
m15*0.1
nodelay
--
0
PMID: 18400190 Importantly, the genes encoding the Socs proteins are direct targets of Stat proteins; the Jak-Stat cascades thereby control their own signaling output by feedback inhibition.
p38
p38
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c94 : 1
stoichiometry:c95 : 1
stoichiometry:c96 : 1
stoichiometry:c98 : 1
stoichiometry:c97 : 1
m38*m39*m3559*m3558*m41*0.1
nodelay
--
0
PMID: 18400190, 12076535, 10051596 Each of the eight Socs proteins have two major domains, an SH2 domain and a Socs box that complexes with elongins B and C, a cullin and Rbx2, to form a E3 ubiquitin ligase.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c99 : 1
stoichiometry:c100 : 1
stoichiometry:c101 : 1
m40*m13*0.1
nodelay
--
0
PMID: 18400190 The Socs SH2 domains bind phosphorylated tyrosine residues in their substrates. The best characterized Socs substrates are specific tyrosine residues in the cytoplasmic tails of cytokine receptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c8 : 1
stoichiometry:c9 : 1
stoichiometry:c10 : 1
m12*m1633*0.1
nodelay
--
0
PMID: 18400190 This event provides a docking site for proteins with Src homology 2 domains, one important class of which is the Stat family of transcription factors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c102 : 1
stoichiometry:c103 : 1
m42*0.1
nodelay
--
0
PMID: 18400190 The current model of Socs function postulates that the E3 activity of a Socs protein will target the substrate to be ubiquitinated and then directed to the proteosome for degradation.
p41
p41
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c104 : 1
stoichiometry:c105 : 1
m43*0.1
nodelay
--
0
PMID: 18400190 The current model of Socs function postulates that the E3 activity of a Socs protein will target the substrate to be ubiquitinated and then directed to the proteosome for degradation.
p42
p42
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c106 : 1
stoichiometry:c107 : 1
stoichiometry:c108 : 1
m464*m63352*0.1
nodelay
--
0
PMID: 18400190 The G-CSFR is responsible for transducing the signals from G-CSF via four tyrosine residues located in the cytoplasmic tail of the receptor.
p43
p43
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c109 : 1
stoichiometry:c111 : 1
stoichiometry:c110 : 1
m1798*m44*0.1
nodelay
--
0
PMID: 18400190 G-CSFR signaling via the cytoplasmic tyrosines activates numerous signaling molecules including Stat5, Stat3, and MAP kinases.
p44
p44
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c112 : 1
stoichiometry:c114 : 1
stoichiometry:c121 : 1
stoichiometry:c113 : 1
m1360*m44*0.1
nodelay
--
0
PMID: 18400190 G-CSFR signaling via the cytoplasmic tyrosines activates numerous signaling molecules including Stat5, Stat3, and MAP kinases. PMID: 18400190, 12133942 Indeed, Socs3 binds to one of the tyrosine residues in the G-CSFR (Y729) and restricts the amplitude of Stat3 signaling.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c118 : 1
stoichiometry:c119 : 1
stoichiometry:c120 : 1
m44*m2005*0.1
nodelay
--
0
PMID: 18400190, 12133942 Indeed, Socs3 binds to one of the tyrosine residues in the G-CSFR (Y729) and restricts the amplitude of Stat3 signaling.
p46
p46
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c115 : 1
stoichiometry:c116 : 1
stoichiometry:c117 : 1
m44*m1812*0.1
nodelay
--
0
PMID: 18400190 G-CSFR signaling via the cytoplasmic tyrosines activates numerous signaling molecules including Stat5, Stat3, and MAP kinases.
PMID: 18400190 Thus, loss of Socs3 causes increased G-CSFR signaling leading to increased neutrophil numbers, whereas loss of Stat3 (and failure to induce Socs3 expression) also leads to increased neutrophil numbers.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c124 : 1
stoichiometry:c123 : 1
m31*0.1
nodelay
--
0
PMID: 18400190 Thus, loss of Socs3 causes increased G-CSFR signaling leading to increased neutrophil numbers, whereas loss of Stat3 (and failure to induce Socs3 expression) also leads to increased neutrophil numbers. PMID: 18400190 Socs3 expression is strongly induced by IL-10, along with the Stat3-dependent genes whose products regulate the anti-inflammatory signaling system (¡Èanti-inflammatory response¡É AIR gene whose identity has yet to be determined) illustrated as inhibiting the expression at the transcriptional level of classic pro-inflammatory genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c129 : 1
stoichiometry:c125 : 1
m31*0.1
nodelay
--
0
PMID: 18400190 Socs3 expression is strongly induced by IL-10, along with the Stat3-dependent genes whose products regulate the anti-inflammatory signaling system (¡Èanti-inflammatory response¡É AIR gene whose identity has yet to be determined) illustrated as inhibiting the expression at the transcriptional level of classic pro-inflammatory genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m1633*0.1
nodelay
--
0
PMID: 18400190, 14668806 With seven members in all (Stat1, Stat2, Stat3, Stat4, Stat5a, Stat5b, and Stat6), these DNA-binding proteins provide a rapid membrane to nucleus mechanism for regulation of gene expression.
p50
p50
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c126 : 1
stoichiometry:c139 : 1
stoichiometry:c127 : 1
m1360*m67*0.1
nodelay
--
0
PMID: 18400190 Socs3 expression is strongly induced by IL-10, along with the Stat3-dependent genes whose products regulate the anti-inflammatory signaling system (¡Èanti-inflammatory response¡É AIR gene whose identity has yet to be determined) illustrated as inhibiting the expression at the transcriptional level of classic pro-inflammatory genes.
p51
p51
cso30:i:ME_Translocation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c57 : 1
stoichiometry:c146 : 1
stoichiometry:c52 : 1
m19*m1360*0.1
nodelay
--
0
PMID: 18400190 Gp130 has multiple tyrosine residues in its cytoplasmic tail, all of which bar one, Y757, serve as docking sites for Stat proteins (especially Stat3) PMID: 18400190 Socs3 is an important inhibitor of cytokines that use gp130 (IL-23R and IL-6R), whereas Socs1 is anticipated to inhibit any cytokines that use gamma-c (IL-7, IL-21 as shown).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c130 : 1
stoichiometry:c147 : 1
stoichiometry:c131 : 1
m29*m1360*0.1
nodelay
--
0
PMID: 18400190 Gp130 has multiple tyrosine residues in its cytoplasmic tail, all of which bar one, Y757, serve as docking sites for Stat proteins (especially Stat3) PMID: 18400190 Socs3 is an important inhibitor of cytokines that use gp130 (IL-23R and IL-6R), whereas Socs1 is anticipated to inhibit any cytokines that use gamma-c (IL-7, IL-21 as shown).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c134 : 1
stoichiometry:c135 : 1
stoichiometry:c136 : 1
m49*0.1
nodelay
--
0
PMID: 18400190, 16698929, 17884812 However, Stat3 also directly regulates the expression of Il21 and Il17.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c137 : 1
stoichiometry:c138 : 1
stoichiometry:c128 : 1
m64*0.1
nodelay
--
0
PMID: 18400190, 16698929, 17884812 However, Stat3 also directly regulates the expression of Il21 and Il17.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c140 : 1
stoichiometry:c144 : 1
stoichiometry:c142 : 1
m19*m2005*0.1
nodelay
--
0
PMID: 18400190, 16678769, 12687404 Y757 docks the SH2 domain of Socs3 and is by far the best-characterized Socs-cytokine receptor interaction.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c141 : 1
stoichiometry:c145 : 1
stoichiometry:c143 : 1
m29*m2005*0.1
nodelay
--
0
PMID: 18400190, 16678769, 12687404 Y757 docks the SH2 domain of Socs3 and is by far the best-characterized Socs-cytokine receptor interaction.
p57
p57
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c154 : 1
stoichiometry:c153 : 1
m4068*0.1
nodelay
--
0
PMID: 18400190, 18276893 IL-22 induces the expression of antimicrobial proteins, including S1008A, a zinc and manganese chelating protein that deprives bacteria of essential cations.
p58
p58
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c156 : 1
stoichiometry:c155 : 1
m1947*0.1
nodelay
--
0
PMID: 18400190 Socs1, unlike the broad expression of Socs3, is activated predominantly by interferon signaling, although other cytokines such as IL-4 also activate Socs1 expression but in a cell-type-dependent way.
p59
p59
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c158 : 1
stoichiometry:c159 : 1
stoichiometry:c157 : 1
m69*m98717*0.1
nodelay
--
0
PMID: 18400190 Because TLR signaling induces autocrine-paracrine IFN-alpha-beta production, this might underlie the cause of LPS sensitivity in Socs1¡Ý/¡Ý; Ifng¡Ý/¡Ý mice.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m14*m16*0.1
nodelay
--
0
PMID: 18400190, 14668806 With seven members in all (Stat1, Stat2, Stat3, Stat4, Stat5a, Stat5b, and Stat6), these DNA-binding proteins provide a rapid membrane to nucleus mechanism for regulation of gene expression.
p60
p60
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c161 : 1
stoichiometry:c162 : 1
stoichiometry:c160 : 1
m93217*m69*0.1
nodelay
--
0
PMID: 18400190 Because TLR signaling induces autocrine-paracrine IFN-alpha-beta production, this might underlie the cause of LPS sensitivity in Socs1¡Ý/¡Ý; Ifng¡Ý/¡Ý mice.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c166 : 1
stoichiometry:c167 : 1
stoichiometry:c168 : 1
m70*m1906*0.1
nodelay
--
0
PMID: 18400190, 16415872 Mansell et al. have demonstrated that Socs1 can bind to and regulate the degradation of Mal (also known as TIRAP), an adaptor molecule specifically associated with TLR2 and TLR4 signaling.
p62
p62
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c163 : 1
stoichiometry:c164 : 1
stoichiometry:c165 : 1
m367*m43675*0.1
nodelay
--
0
PMID: 18400190, 16439361 Previous studies had shown that the tyrosine kinase Btk phosphorylates Mal, providing binding sites for Socs1.
p63
p63
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c169 : 1
stoichiometry:c170 : 1
stoichiometry:c171 : 1
m71*0.1
nodelay
--
0
PMID: 18400190, 16415872 Mansell et al. have demonstrated that Socs1 can bind to and regulate the degradation of Mal (also known as TIRAP), an adaptor molecule specifically associated with TLR2 and TLR4 signaling.
p64
p64
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c173 : 1
stoichiometry:c175 : 1
stoichiometry:c179 : 1
stoichiometry:c174 : 1
m2033*m3609*0.1
nodelay
--
0
PMID: 18400190 The chemokine CXCL12 activates CXCR4 and induces phosphorylation of FAK, a ubiquitous tyrosine kinase, in addition to other pathways. PMID: 18400190, 12163560 Therefore, the assignment of FAK as a substrate of Socs3 potentially explains previous data that suggested that Socs3 directly regulates CXCR4 to inhibit its activity.
p65
p65
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c176 : 1
stoichiometry:c178 : 1
stoichiometry:c182 : 1
stoichiometry:c177 : 1
m1787*m3609*0.1
nodelay
--
0
PMID: 18400190 The chemokine CXCL12 activates CXCR4 and induces phosphorylation of FAK, a ubiquitous tyrosine kinase, in addition to other pathways. PMID: 18400190 Le et al. have shown that Socs3 is crucial to regulate the amounts of CXCL12-activated phospho-FAK because Socs3-deficient B cells have increased amount of phospho-FAK.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c180 : 1
stoichiometry:c181 : 1
1.0*0.1
nodelay
--
0
PMID: 18400190, 12387736 Link and colleagues have also postulated that signals from the G-CSFR negatively regulate CXCL12 amounts in the bone marrow, thereby allowing escape of neutrophils into the circulation.
p67
p67
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c183 : 1
stoichiometry:c184 : 1
stoichiometry:c185 : 1
m69*m74*0.1
nodelay
--
0
PMID: 18400190 Addressing this question is complicated by the diversity of stimuli and downstream signaling molecules that contribute to myeloid IL-10 production including TLR agonists via TLRs and the p38 MAP kinase pathways and zymosan via the dectin and ERK pathways, to list a few.
p68
p68
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c189 : 1
stoichiometry:c194 : 1
stoichiometry:c187 : 1
m94230*m78*0.1
nodelay
--
0
PMID: 18400190 Addressing this question is complicated by the diversity of stimuli and downstream signaling molecules that contribute to myeloid IL-10 production including TLR agonists via TLRs and the p38 MAP kinase pathways and zymosan via the dectin and ERK pathways, to list a few.
p69
p69
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c186 : 1
stoichiometry:c190 : 1
stoichiometry:c188 : 1
m75*m94230*0.1
nodelay
--
0
PMID: 18400190 Addressing this question is complicated by the diversity of stimuli and downstream signaling molecules that contribute to myeloid IL-10 production including TLR agonists via TLRs and the p38 MAP kinase pathways and zymosan via the dectin and ERK pathways, to list a few.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m1767*m17*0.1
nodelay
--
0
PMID: 18400190 As an example of the overall importance of cytokine-cytokine receptor-Jak-Stat pathway signaling in thymic T cell development, IL-7 signaling ensures development of appropriate lymphocyte numbers. PMID: 18400190 Stat5 signaling from cytokines that use ¦Ãc is essential for T cell development.
p70
p70
cso30:i:ME_UnknownActivation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c191 : 1
stoichiometry:c193 : 1
stoichiometry:c192 : 1
m76*m77*0.1
nodelay
--
0
PMID: 18400190 Addressing this question is complicated by the diversity of stimuli and downstream signaling molecules that contribute to myeloid IL-10 production including TLR agonists via TLRs and the p38 MAP kinase pathways and zymosan via the dectin and ERK pathways, to list a few.
p71
p71
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c195 : 1
stoichiometry:c197 : 1
stoichiometry:c196 : 1
m1357*m37778*0.1
nodelay
--
0
PMID: 18400190, 18400189 Aspects of this complex regulatory pathway including the role of IL-27 in driving IL-10 production via Stat1 and Stat3 are covered in the review by Li and Flavell, (2008).
p72
p72
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c199 : 1
stoichiometry:c205 : 1
stoichiometry:c198 : 1
m94230*m79*0.1
nodelay
--
0
PMID: 18400190, 18400189 Aspects of this complex regulatory pathway including the role of IL-27 in driving IL-10 production via Stat1 and Stat3 are covered in the review by Li and Flavell, (2008).
p73
p73
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c200 : 1
stoichiometry:c204 : 1
stoichiometry:c201 : 1
m1360*m37778*0.1
nodelay
--
0
PMID: 18400190, 18400189 Aspects of this complex regulatory pathway including the role of IL-27 in driving IL-10 production via Stat1 and Stat3 are covered in the review by Li and Flavell, (2008).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c203 : 1
stoichiometry:c202 : 1
m31*0.1
nodelay
--
0
PMID: 18400190, 18400189 Aspects of this complex regulatory pathway including the role of IL-27 in driving IL-10 production via Stat1 and Stat3 are covered in the review by Li and Flavell, (2008).
p8
p8
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c21 : 1
stoichiometry:c19 : 1
stoichiometry:c148 : 1
stoichiometry:c20 : 1
m18*m1798*0.1
nodelay
--
0
PMID: 18400190 Stat5 signaling from cytokines that use ¦Ãc is essential for T cell development. PMID: 18400190 Socs3 is an important inhibitor of cytokines that use gp130 (IL-23R and IL-6R), whereas Socs1 is anticipated to inhibit any cytokines that use gamma-c (IL-7, IL-21 as shown).
p9
p9
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c26 : 1
stoichiometry:c149 : 1
stoichiometry:c23 : 1
m1364*m18*0.1
nodelay
--
0
PMID: 18400190, 16418296 IL-7 activates Stat5a and Stat5b, and deletion of the locus encoding Stat5a and Stat5b also results in a severe SCID phenotype. PMID: 18400190 Socs3 is an important inhibitor of cytokines that use gp130 (IL-23R and IL-6R), whereas Socs1 is anticipated to inhibit any cytokines that use gamma-c (IL-7, IL-21 as shown).
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--